The Effect of Oxygen Therapy in Acute Myocardial Infraction

Comparison of The Effect of Taking Oxygen with Not Taking Oxygen in the Prognosis of Patients with Acute Myocardial Infarction

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200901048576N1

Enrollment

Registered

2021-03-15

Start date

2019-03-25

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction.

Interventions

Intervention 1: Intervention group: 25 people are randomly selected to receive oxygen through an oral mask at 6 litres per minute during the 6 to 12 hours of emergency hospitalization. Intervention 2:

Eligibility

Sex/Gender

All

Age

30 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who present to emergency department Zahedan University Hospital Patients who have symptoms suggestive of MI ECG changes with elevated cardiac troponin Oxygen saturation of 90% or higher on pulse oximetry Patients who have Iranian nationality Patients who orally are agreed to participate and have signed consent forms

Exclusion criteria

Exclusion criteria: Patients who have continuous oxygen therapy Patients who have suffered cardiac arrest prior to inclusion If supplemental oxygen therapy is started before evaluation for inclusion for less than 20 minutes, new evaluation can take place after discontinuation of oxygen delivery and ten minutes of wash-out .

Design outcomes

Primary

Measure	Time frame
The mortality rate of people who were diagnosed by MI and have been treated with oxygen. Timepoint: During one and three months after oxygen therapy. Method of measurement: Number of patients who died or survived during follow-up.;The mortality rate in people with acute MI without receiving oxygen. Timepoint: During one and three months after oxygen therapy. Method of measurement: Number of patients who died or survived during follow-up.;The rate of re-hospitalization of people due to acute MI with receiving oxygen. Timepoint: During one and three months after oxygen therapy. Method of measurement: Re-hospitalization (measured by the number of patients who have been re-admitted for three months).;The rate of re-hospitalization of people due to acute MI without receiving oxygen. Timepoint: During one and three months after oxygen therapy. Method of measurement: Re-hospitalization (measured by the number of patients who have been re-admitted for three months).	—

Measure

Time frame

The mortality rate of people who were diagnosed by MI and have been treated with oxygen. Timepoint: During one and three months after oxygen therapy. Method of measurement: Number of patients who died or survived during follow-up.;The mortality rate in people with acute MI without receiving oxygen. Timepoint: During one and three months after oxygen therapy. Method of measurement: Number of patients who died or survived during follow-up.;The rate of re-hospitalization of people due to acute MI with receiving oxygen. Timepoint: During one and three months after oxygen therapy. Method of measurement: Re-hospitalization (measured by the number of patients who have been re-admitted for three months).;The rate of re-hospitalization of people due to acute MI without receiving oxygen. Timepoint: During one and three months after oxygen therapy. Method of measurement: Re-hospitalization (measured by the number of patients who have been re-admitted for three months).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Zeiaesaeidi

Zahedan University of Medical Sciences

mahsa.zsd@zaums.ac.ir+98 54 3344 4304

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026